Anavex Life Sciences Corp (AVXL)
5.145
-0.42
(-7.46%)
USD |
NASDAQ |
Sep 06, 16:00
5.15
0.00 (0.00%)
After-Hours: 20:00
Anavex Life Sciences Price: 5.145 for Sept. 6, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 06, 2024 | 5.53 | 5.60 | 5.09 | 5.145 | 755238.0 |
| Sep 05, 2024 | 5.62 | 5.621 | 5.45 | 5.56 | 526097.0 |
| Sep 04, 2024 | 5.51 | 5.79 | 5.44 | 5.62 | 501660.0 |
| Sep 03, 2024 | 6.02 | 6.06 | 5.26 | 5.46 | 1.405M |
| Aug 30, 2024 | 6.00 | 6.02 | 5.85 | 6.02 | 549988.0 |
| Aug 29, 2024 | 5.92 | 6.20 | 5.91 | 5.97 | 543998.0 |
| Aug 28, 2024 | 6.06 | 6.156 | 5.84 | 5.88 | 631815.0 |
| Aug 27, 2024 | 6.30 | 6.35 | 6.07 | 6.08 | 440582.0 |
| Aug 26, 2024 | 6.33 | 6.64 | 6.27 | 6.36 | 632723.0 |
| Aug 23, 2024 | 6.17 | 6.50 | 6.15 | 6.32 | 682357.0 |
| Aug 22, 2024 | 6.36 | 6.36 | 6.105 | 6.13 | 467167.0 |
| Aug 21, 2024 | 6.19 | 6.39 | 6.06 | 6.35 | 802899.0 |
| Aug 20, 2024 | 6.25 | 6.27 | 6.03 | 6.13 | 369544.0 |
| Aug 19, 2024 | 6.08 | 6.30 | 5.99 | 6.28 | 642844.0 |
| Aug 16, 2024 | 6.29 | 6.36 | 5.93 | 6.09 | 717090.0 |
| Aug 15, 2024 | 6.32 | 6.46 | 6.210 | 6.31 | 549434.0 |
| Aug 14, 2024 | 6.47 | 6.47 | 6.125 | 6.175 | 546677.0 |
| Aug 13, 2024 | 6.21 | 6.53 | 6.20 | 6.42 | 494552.0 |
| Aug 12, 2024 | 6.37 | 6.385 | 6.08 | 6.16 | 598073.0 |
| Aug 09, 2024 | 6.71 | 6.71 | 6.23 | 6.305 | 651942.0 |
| Aug 08, 2024 | 6.10 | 6.73 | 6.10 | 6.64 | 812255.0 |
| Aug 07, 2024 | 7.00 | 7.16 | 6.055 | 6.08 | 1.303M |
| Aug 06, 2024 | 6.65 | 7.10 | 6.330 | 6.815 | 1.148M |
| Aug 05, 2024 | 5.81 | 6.76 | 5.77 | 6.45 | 1.383M |
| Aug 02, 2024 | 6.31 | 6.62 | 6.16 | 6.495 | 1.265M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
2.31
Minimum
Nov 22 2019
28.86
Maximum
Jun 28 2021
8.775
Average
8.02
Median
Jul 25 2023
Price Benchmarks
| Biogen Inc | 200.76 |
| Bruker Corp | 64.00 |
| Cassava Sciences Inc | 26.91 |
| BioXcel Therapeutics Inc | 0.5408 |
| Mirum Pharmaceuticals Inc | 41.16 |
Price Related Metrics
| Price to Book Value | 3.362 |
| Earnings Yield | -9.91% |
| Market Cap | 436.27M |